The SERENITY Study: Online Mindfulness-Based Cancer Recovery for Patients With Gynecological Cancer
SERENITY
Online Mindfulness-Based Cancer Recovery (MBCR) Program for Patients Living With a Gynecological Cancer: a Pilot Randomized Controlled Study.
1 other identifier
interventional
62
1 country
2
Brief Summary
The overall objective of this project is to explore the feasibility, acceptability and potential effects of the online MBCR program in gynecological cancer settings. This will provide preliminary efficacy data in prevision of a larger, confirmatory, randomized controlled trial. As this study will be one of the first led in a French speaking country and the first conducted in a university hospital environment in Switzerland, the investigators would like to investigate the early implementation of this program among professionals and patients. Furthermore, they will investigate if in the online MBCR group, participants will show improvement in psychosocial outcomes, consumption of psychotropic and opioid medication, spirituality and meaning in life and in different biological processes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2019
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 19, 2019
CompletedFirst Submitted
Initial submission to the registry
August 22, 2020
CompletedFirst Posted
Study publicly available on registry
September 25, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedNovember 29, 2022
November 1, 2022
2.5 years
August 22, 2020
November 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participants' attendance to the program
Number of overall sessions attended - patients are expected to attend at least 5 of the 10 sessions planned (including the 6-h retreat)
Within 3 weeks of completion of the intervention
Secondary Outcomes (27)
Acceptability of the program (quantitative)
Every week during the intervention and within 3 weeks of completion of the intervention
Acceptability of the program (qualitative)
Every week during the intervention and within 3 weeks of completion of the intervention
Appropriateness of the program (quantitative)
Within 3 weeks of completion of the intervention
Appropriateness of the program (qualitative)
Within 3 weeks of completion of the intervention
Fidelity of the program
Within 3 weeks of completion of the intervention
- +22 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALOnline Mindfulness-Based Cancer Recovery
Control group
NO INTERVENTIONTreatment as usual
Interventions
Mindfulness-Based Cancer Recovery (MBCR) is a standardized group program which focuses primarily on the challenges faced by people living with cancer. It is an 8-week program consisting of weekly group meetings of 1.5 to 2 hours. Home practice of 45 minutes per day (15 min yoga; 30 min meditation) is prescribed. As the weeks progress, different forms of meditation are introduced, beginning with a body scan sensory awareness experience, progressing to sitting and walking meditations. Gentle Hatha yoga is incorporated throughout, as a form of moving meditation. Didactic instruction as well as group discussion and reflection, problem solving and skillful inquiry are commonly applied teaching tools.
Eligibility Criteria
You may qualify if:
- ≥ 18 years
- Being a woman
- Being diagnosed with breast or any gynecological cancer (either ovarian, cervical, vulvar, womb or vaginal cancer), stages I to IV.
- For women with localized cancers: having completed all adjuvant treatments, such as surgery, chemotherapy and/or radiotherapy, at least 3 months previously, with the exception of hormonal, immune and targeted therapy,
- For women with metastatic cancers: having a performance status \< 3, not undergoing IV chemotherapy and having a life expectancy more than 9 months as estimated by their treating oncologist.
- Free from acute infection for 2 weeks before biochemical assessment.
- Speaking and reading French fluently
- Be able to follow the online course via a computer/tablet
You may not qualify if:
- Inability to follow the procedures of the study due to:
- Significant deafness
- Physical impairment that prevents attending the sessions
- Mental retardation (ICD-10)
- Dementia (ICD-10)
- Depression (ICD-10) \*
- Spectrum disorder of schizophrenia (ICD-10) \*\*
- Alcohol or other substance dependence (ICD-10) \*\*
- Emotionally labile personality disorder that is incompatible with group participation (ICD-10) \*\*
- A post-traumatic stress disorder (PTSD) (ICD-10)\*\*
- Currently engages in meditation one or more times per week
- Previous participation in an MBI program
- Serious physiological illnesses that would interfere with the interpretation of biochemical data (e.g., anemia, diabetes, cardiovascular diseases, blood cancers, inflammatory bowel diseases, autoimmune diseases, asthma being treated with steroids, immunodeficiency)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpitaux Universitaires de Genève (HUG)
Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Switzerland
Related Publications (1)
Gaignard ME, Martin D, Stanic J, Hilfiker R, Bodmer A, Ljuslin M, Zaman K, Labidi-Galy I, Sarivalasis A, Carlson LE, Peters S, Dietrich PY, Eicher M, Bondolfi G, Jermann F. The Experience of Women With Breast or Gynecological Cancer After Participation in an Online Mindfulness-Based Cancer Recovery (e-MBCR) Program: Secondary Outcomes Analysis of a Pilot Mixed Methods Randomized Controlled Trial. Psychooncology. 2025 Nov;34(11):e70334. doi: 10.1002/pon.70334.
PMID: 41272951DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 22, 2020
First Posted
September 25, 2020
Study Start
December 19, 2019
Primary Completion
June 30, 2022
Study Completion
September 30, 2022
Last Updated
November 29, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share